Maastricht University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Maastricht University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12363
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Maastricht University (MU) is an educational service provider that offers academic programs such as bachelor degree, master and doctoral programs. The university offers postgraduate research degrees in various subjects for a range of research needs and interests. It offers programs through its faculties and schools of arts and social sciences, business and economics, health, medicine and life sciences, humanities and sciences, law, and graduate school of governance, among others. The university also offers scientific research and education services in the STEM disciplines. MU is headquartered in Maastricht, the Netherlands.

Maastricht University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9
Maastricht University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Maastricht University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Glucox Biotech Enters Into Collaboration with Maastricht University 11
Basic Pharma Enters into Co-Development Agreement with Maastricht University 12
Licensing Agreements 13
Mirabilis Therapeutics Enters into Licensing Agreement with Maastricht University and Maastricht University Medical 13
Matisse Pharma Enters into Licensing Agreement with Maastricht University 14
Equity Offering 15
CiMaas Spins Out from Maastricht University Medical Center 15
Maastricht University – Key Competitors 16
Maastricht University – Key Employees 17
Maastricht University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Other Significant Developments 19
Aug 09, 2018: New study views cancer treatment as a game to find strategies that improve patient outcomes 19
Jan 19, 2017: CiMaas starts 2017 with successful first investment 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Maastricht University, Pharmaceuticals & Healthcare, Key Facts 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9
Maastricht University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Glucox Biotech Enters Into Collaboration with Maastricht University 11
Basic Pharma Enters into Co-Development Agreement with Maastricht University 12
Mirabilis Therapeutics Enters into Licensing Agreement with Maastricht University and Maastricht University Medical 13
Matisse Pharma Enters into Licensing Agreement with Maastricht University 14
CiMaas Spins Out from Maastricht University Medical Center 15
Maastricht University, Key Competitors 16
Maastricht University, Key Employees 17
Maastricht University, Subsidiaries 18

List of Figures
Maastricht University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Maastricht University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • Marriott Vacations Worldwide Corporation:企業の戦略・SWOT・財務情報
    Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • 2020 GeneSystems Inc-製薬・医療分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • Rex Energy Corporation (REXX)-石油・ガス分野:企業M&A・提携分析
    Summary Rex Energy Corporation (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds properties in Appalachian Basin. Rex Energy focuses on drilling and exploration activitie …
  • Synergy:企業の戦略・SWOT・財務情報
    Synergy - Strategy, SWOT and Corporate Finance Report Summary Synergy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • Pioneer Hi-Bred International Inc:企業のM&A・事業提携・投資動向
    Pioneer Hi-Bred International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pioneer Hi-Bred International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Cipher Pharmaceuticals Inc (CPH):企業の財務・戦略的SWOT分析
    Summary Cipher Pharmaceuticals Inc (Cipher) is a pharmaceutical company that develops skin care solutions. The company provides products such as actikerall, a topical solution indicated for the treatment of hyperkeratotic actinic keratosis; beteflam, a topical patch used for the treatment of mild to …
  • CNH Industrial NV:企業の戦略・SWOT・財務情報
    CNH Industrial NV - Strategy, SWOT and Corporate Finance Report Summary CNH Industrial NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mologen AG:企業のM&A・事業提携・投資動向
    Mologen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mologen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • PEPKOR RETAIL LIMITED:企業の戦略・SWOT・財務分析
    PEPKOR RETAIL LIMITED - Strategy, SWOT and Corporate Finance Report Summary PEPKOR RETAIL LIMITED - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • First Light Biosciences Inc:企業の製品パイプライン分析2018
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes multipath analyzer system. Its multipath analyzer system detects resistant …
  • Edge Therapeutics Inc (EDGE)-製薬・医療分野:企業M&A・提携分析
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, …
  • Nostra Terra Oil and Gas Company plc (NTOG):企業の財務・戦略的SWOT分析
    Summary Nostra Terra Oil and Gas Company Plc (NTOG) is an oil and gas company. The company explores, produces, and develops oil and gas properties across the US. It holds interest in operating and non-operating working interests in its projects located in Texas, New Mexico, Wyoming, Kansas, Colorado …
  • Caisse de depot et placement du Quebec:企業の戦略・SWOT・財務分析
    Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report Summary Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China Life Insurance (Overseas) Company Limited:企業の戦略・SWOT・財務情報
    China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • CTI Clinical Trial and Consulting Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CTI Clinical Trial and Consulting Services Inc (CTI) is a contract research company (CRO) that offers clinical trial and consulting services. The company offers services such as project management, clinical data management, biostatistics, clinical monitoring, safety and pharmacovigilance and …
  • Ferrovial, S.A.:企業の戦略・SWOT・財務分析
    Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report Summary Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Yakult Honsha Co Ltd (2267):企業の財務・戦略的SWOT分析
    Yakult Honsha Co Ltd (2267) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆